Abstract
The specific red cell adherence (SRCA) test used previously as a prognostic indicator of bladder tumors was used in a retrospective review of 14 patients with transitional cell carcinoma of the ureter and renal pelvis. SRCA-positive individuals appear to have better survival and progress less frequently to metastatic disease. Of five patients with positive reactions, none had distant metastases. Conversely, in SRCA-negative individuals metastatic disease developed more frequently (4 of 9). The SRCA test can be as useful a test of the prognosis of ureteral and renal pelvis tumors as it is of urinary bladder tumors.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 361-365 |
| Number of pages | 5 |
| Journal | Urology |
| Volume | 19 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 1982 |
ASJC Scopus subject areas
- Urology
Fingerprint Dive into the research topics of 'Specific red cell adherence test applied to tumors of ureter and renal pelvis'. Together they form a unique fingerprint.
Cite this
Gruber, M. B., Becker, S. N., Warren, M. M., Rambo, M. J., & Davis, C. P. (1982). Specific red cell adherence test applied to tumors of ureter and renal pelvis. Urology, 19(4), 361-365. https://doi.org/10.1016/0090-4295(82)90189-3